Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," ...

The average age of men who get diagnosed is 67.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.

Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...

Longtime friends and allies of former President Joe Biden are worried about the toll cancer treatment is taking on the ...